|
Status |
Public on Jun 21, 2022 |
Title |
Kp-HW |
Sample type |
SRA |
|
|
Source name |
hematopoietic cells (K562 cells)
|
Organism |
Homo sapiens |
Characteristics |
cell type: chronic myelogeneous leukemia cell treatment (transfection): pMYs-IG_3xHA-EVI1-WT expression type: stably expressed expression level: retroviral overexpression cell line: K562
|
Growth protocol |
K562 cells were cultured with RPMI-1640 supplemented with 10% fetal bovine serum, 100 u/ml penicillin, and 100 µg/ml streptomycin.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using RNeasy mini kit (Qiagen) following the manufacturer’s protocol TruSeq RNA Library Kit v2
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NovaSeq 6000 |
|
|
Data processing |
bcl2fastq nf-core/rnaseq 3.0 Genome_build: hg19 Supplementary_files_format_and_content: gene expression (counts, TPMs, FPKMs)
|
|
|
Submission date |
Dec 10, 2021 |
Last update date |
Jun 23, 2022 |
Contact name |
Masaki Nomura |
E-mail(s) |
[email protected]
|
Organization name |
Foundation for Biomedical Research and Innovation at Kobe
|
Street address |
6-3-7 Minatojima Minamimachi, Chuo Ward
|
City |
Kobe |
State/province |
Hyogo |
ZIP/Postal code |
650-0047 |
Country |
Japan |
|
|
Platform ID |
GPL24676 |
Series (2) |
GSE190653 |
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia [K562_RNA-seq] |
GSE190656 |
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia |
|
Relations |
BioSample |
SAMN23887323 |
SRA |
SRX13377254 |